Ventricular reconstruction surgery for congestive heart failure

Richard Lee1, Katherine J Hoercher, Patrick M McCarthy

  • 1Department of Thoracic and Cardiovascular Surgery, George M and Linda H Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

Cardiology
|February 28, 2004
PubMed

Insights

Heart failure is a growing concern, and donor organ shortages limit transplantation. Surgical treatments, including novel left ventricular reconstruction, are being re-evaluated for end-stage heart failure.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Technology

Background:

  • Increasing prevalence of heart failure in the US presents a significant public health challenge.
  • Limited availability of donor organs restricts the widespread application of heart transplantation for end-stage heart failure.
  • This necessitates a re-examination of surgical treatment options for heart failure.

Purpose of the Study:

  • To review and discuss the evolution and application of surgical therapies for heart failure.
  • To highlight the importance of addressing left ventricular (LV) geometry in failing hearts.
  • To explore novel surgical approaches beyond conventional methods.

Main Methods:

  • Review of existing surgical techniques for heart failure.
  • Analysis of the role of left ventricular reconstruction in managing heart failure.
  • Discussion of advancements in surgical treatment strategies.

Main Results:

  • Surgical therapies are evolving from traditional procedures like coronary artery bypass surgery.
  • Novel left ventricular (LV) reconstruction operations are emerging as important interventions.
  • These novel operations specifically target the geometry of the left ventricle, a critical factor in heart failure.

Conclusions:

  • Surgical interventions are crucial in managing end-stage heart failure, especially given donor organ limitations.
  • Left ventricular reconstruction represents a significant advancement in addressing the underlying pathophysiology of heart failure.
  • Continued research and application of novel surgical techniques are vital for improving outcomes in heart failure patients.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...